According to Simon's optimal two-stage design, 25 patients were required for enrollment to test the null hypothesis that the true ORR is 10% versus the alternative hypothesis that the true ORR is at least 30%, at a significance level of p<0.05 with a power of 80%. If two or more responses were observed among 15 patients in the first stage, the study was continued with 10 additional patients included. As the drop-out rate was assumed to be 10%, the number of patients necessary for recruitment into the study was calculated to be 28.

Descriptive statistics were used to summarize the patients' characteristics, tumor responses, and safety events. The Kaplan-Meier method was used to estimate the median PFS and OS. All enrolled patients were included in an intent-to-treat analysis.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.